RxDoctor Payments DataLook up a doctor →

Surena Namdari, MD

Orthopaedic Surgery · Philadelphia, PANPI 1255539938

Payments from drug & device makers

$1,844,058in general payments, 2019–2025

Across 514 payments — averaging $3587.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$1.7M
  • Insight Medical Systems, Inc.$40K
  • Zimmer Biomet$40K
  • Biedermann Motech, Inc.$22K
  • Medical Device Business Services, Inc.$15K
  • Davol Inc.$7K
  • plus $25K from 15 others

What the payments were for

  • Royalty or licence$1,025,49558%
  • Consulting fees$710,28440%
  • Speaking & faculty fees$1,0500%
  • Travel & lodging$36,9942%
  • Food & beverage$6,7070%
  • Education$2,8290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,844,058 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$339,377
Medicare patients
664
Services billed
3,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate56$647
Methylprednisolone87$438
Ketorolac Tromethamine14$238
Tramadol Hcl163$220
Oxycodone Hcl87$206
Naproxen14$46
Amoxicillin30$29
Ibuprofen14$11

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →